PRESS RELEASE published on 01/12/2026 at 17:40, 1 month 1 day ago VALBIOTIS SA: Valbiotis annonce une nouvelle publication scientifique majeure pour TOTUM-448, substance active pour les maladies métaboliques du foie (MASLD) Valbiotis annonce une nouvelle publication scientifique majeure pour TOTUM-448, substance active pour les maladies métaboliques du foie dans la revue Scientific Reports. Collaborations académiques pour étude chez l'Homme Valbiotis Biodisponibilité TOTUM-448 Maladies Métaboliques Du Foie Publication Scientifique
PRESS RELEASE published on 01/12/2026 at 17:40, 1 month 1 day ago VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD) Valbiotis announces publication in Scientific Reports on TOTUM-448, active substance for metabolic liver disease, presenting results from human study Valbiotis Bioavailability TOTUM-448 Scientific Publication Metabolic Liver Disease
BRIEF published on 01/08/2026 at 17:45, 1 month 5 days ago Valbiotis signs an exclusive distribution agreement in the Middle East Middle East Partnership Valbiotis Dietary Supplements Distribution
BRIEF published on 01/08/2026 at 17:45, 1 month 5 days ago Valbiotis signe un accord de distribution exclusif au Moyen-Orient Partenariat Valbiotis Compléments Alimentaires Distribution Moyen-Orient
BRIEF published on 01/08/2026 at 17:45, 1 month 5 days ago Valbiotis Enters Middle East Market with Exclusive Distribution Deal Distribution Agreement Middle East Valbiotis International Expansion Cardiometabolic Prevention
BRIEF published on 01/08/2026 at 17:45, 1 month 5 days ago Valbiotis fait son entrée sur le marché du Moyen-Orient grâce à un accord de distribution exclusif Expansion Internationale Accord De Distribution Valbiotis Moyen-Orient Prévention Cardiométabolique
PRESS RELEASE published on 01/08/2026 at 17:40, 1 month 5 days ago VALBIOTIS SA: Valbiotis annonce un accord de distribution exclusif au Moyen-Orient Valbiotis annonce un accord de distribution exclusif avec Mena Nutrition pour le Moyen-Orient. Nouvelle étape dans le déploiement international avec des premiers revenus attendus dès fin 2026 Valbiotis Accord Distribution Moyen-Orient Mena Nutrition
PRESS RELEASE published on 01/08/2026 at 17:40, 1 month 5 days ago VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East Valbiotis signs exclusive distribution agreement with Mena Nutrition in Middle East, expanding international reach. Products to focus on cardiometabolic conditions prevention Distribution Agreement Middle East Valbiotis Mena Nutrition Cardiometabolic Conditions
BRIEF published on 12/19/2025 at 11:19, 1 month 25 days ago VALBIOTIS SA publishes monthly data on voting rights and shares Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 12/19/2025 at 11:19, 1 month 25 days ago VALBIOTIS SA publie les données mensuelles sur les droits de vote et actions Droits De Vote Franchissement De Seuil Capital Social Euronext Growth Valbiotis
Published on 02/13/2026 at 22:15, 2 hours 29 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 6 hours 59 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 10 hours 9 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/13/2026 at 14:30, 10 hours 14 minutes ago Golden Harp Resources Inc. Receives TSXV Final Acceptance and Closes Acquisition to Create District-Scale Copper Hill Land Package
Published on 02/13/2026 at 19:20, 5 hours 24 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 5 hours 42 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 6 hours 23 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 6 hours 36 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 17:58, 6 hours 45 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/13/2026 at 18:05, 6 hours 39 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 6 hours 39 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 6 hours 54 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 6 hours 54 minutes ago Nombre total d'actions et droits de vote - janvier 2026
Published on 02/13/2026 at 17:34, 7 hours 9 minutes ago Déclaration des transactions sur actions propres réalisées du 02/02/2026 au 06/02/2026